Iterum Therapeutics - Dublin

Iterum Therapeutics is a clinical-stage pharmaceutical firm working to address the global issue of multi-drug resistant (MDR) pathogens. Their first product is a unique anti-infective compound that has shown strong efficacy against a wide range of gram-positive, gram-negative, and anaerobic bacteria that are resistant to other antibiotics. By creating this innovative solution, Iterum Therapeutics is striving to improve the lives of individuals affected by potentially life-threatening diseases around the world.